1-6 of 6
Carmen Martínez Chamorro
Close
Sort by
Journal Articles

Efficacy and Safety of Less Frequent/Lower Intensity Dosing of Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma: Results from the Phase 1/2 MonumenTAL-1 Study

Ajai Chari, Albert Oriol, Amrita Krishnan, Maria Del Carmen Martinez Chamorro, Luciano Costa, Maria Victoria Mateos, Monique C Minnema, Michela Campagna, Tara J Masterson, Brandi W Hilder, Jaszianne Tolbert, Thomas Renaud, M. Damiette Smit, Swarna Ramanjulu, Paula Rodríguez Otero
Journal: Blood
Blood (2023) 142 (Supplement 1): 1010.
https://doi.org/10.1182/blood-2023-181228
Published: 2023
Journal Articles

Compassionate Use of Belantamab Mafodotin for Treatment of Patients with Relapsed/Refractory Multiple Myeloma Heavily Treated. Spanish Experience

Adrian Alegre, Gonzalo Benzo Callejo, Rafael Alonso Fernández, Joaquin Martínez-López, Ana Jimenez-Ubieto, Clara Cuellar, Elham Askari, Elena Prieto, Concha Alaez, Beatriz Aguado, Alberto Velasco, Isabel Krsnik, Laura Llorente, Cristina Muñoz-Linares, Ana Morales, Eugenio Gimenez Mesa, Rebeca Iglesias, Carmen Martínez-Chamorro, Arancha Alonso, Carmen Jiménez-Montes, María Jesús Blanchard
Journal: Blood
Blood (2021) 138 (Supplement 1): 3775.
https://doi.org/10.1182/blood-2021-151267
Published: 2021
Journal Articles

Acute and Post-Acute COVID-19 Severity and Mortality in Patients with Hematologic Malignancies: A Population-Based Registry Study

Joaquin Martinez-Lopez, Javier De La Cruz, Rodrigo Gil-Manso, Angel Cedillo, Adrian Alegre, Maria Pilar Llamas Sillero, Rafael F. Duarte, Víctor Jiménez-Yuste, jose Angel Hernandez, Mi Kwon, Pedro Sanchez Godoy, Pilar Martinez-Barranco, Blanca Colás Lahuerta, Pilar Herrera Puente, Lauren Benito, Alberto Velasco, Arturo Matilla, Concha Alaez, Rafael Martos, Carmen Martínez-Chamorro, Keina Quiroz, Juan F del Campo, Adolfo De La Fuente, Maria Regina Herraez, Adriana Pascual, Elvira Gomez, Jaime Perez De Oteyza, Elena Ruiz, Jose Luis Diez Martin, Julio Garcia-Suarez
Journal: Blood
Blood (2021) 138 (Supplement 1): 186.
https://doi.org/10.1182/blood-2021-152539
Published: 2021
Journal Articles

Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group

Rebeca Bailén, MD, Mi Kwon, MD PhD, Beatriz Aguado, MD, Rafael F. Duarte, MD PhD FRCP, Maria Calbacho, MD, Anabelle Chinea, MD, Pilar Llamas, MDPhD, Rosalía Riaza Grau, Jose Angel Hernandez-Rivas, MD PhD, Victor Jimenez Yuste, MD PhD, Carmen Martínez-Chamorro, MD, F. Javier Penalver, MD, Ataulfo González, MD, Juan F del Campo, Keina Quiroz, MD, Gillen Oarbeascoa, MD, Julio Garcia Suarez, José Luis Díez-Martín, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-138728
Published: 2020
Journal Articles

Assessment of Clinical Differences Between Starting Antimyeloma Treatment at Biological Relapse or at Clinical Relapse: Preliminary Results of an Observational Prospective Registry

Mercedes Gironella, Juan Bergua, Carlos Fernández de Larrea, Fernando Escalante, Maria González, Carmen Martínez Chamorro, Aurelio López, E Pérez-Persona, Juan José Lahuerta, Nieves Somilinos, Alfonso Soler, Yolanda Gonzalez, Alexia Suárez Cabrera, Abelardo Barez, Valentin Cabañas, Antonia Sampol, Ana Pilar Gonzalez, Giselle Lostaunau, David Vilanova, Adrian Alegre
Journal: Blood
Blood (2015) 126 (23): 4231.
https://doi.org/10.1182/blood.V126.23.4231.4231
Published: 2015
Journal Articles

Bendamustine In Combination With Rituximab As First-Line Treatment For Indolent Non-Hodgkin Lymphoma: Retrospective Analysis Of An Spanish Registry

Silvia Solorzano, Carmen Martinez-Chamorro, Carlos Panizo, Cristina Quero, Guillermo Deben, MD, Jose Paz, Ana Batlle, MD, Alfons Serrano, Zayda Muentes, Antonio Gutierrez, MD, PhD, Jose Francisco Tomas, MD
Journal: Blood
Blood (2013) 122 (21): 5094.
https://doi.org/10.1182/blood.V122.21.5094.5094
Published: 2013